ClearPoint Neuro Inc vs Schwab US Dividend Equity ETF — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Schwab US Dividend Equity ETF trades at $34.27. The key difference: Schwab US Dividend Equity ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | SCHD | |
|---|---|---|
Market Cap | $454.21M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $29.60 | $34.27 |
52-Week Low | $8.66 | $26.44 |
Enterprise Value | $488.79M | — |
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →